Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline

ClinicalTrials.gov ID: NCT01703702

Public ClinicalTrials.gov record NCT01703702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Multicountry Study to Evaluate the Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and to Evaluate the Relationship Between Florbetapir (18F) PET Scan Status and Cognitive Decline

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to determine the effectiveness of florbetapir (18F) in changing patient management and to evaluate the association between scan status and cognitive decline.

Study identification

NCT ID
NCT01703702
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Avid Radiopharmaceuticals
Industry
Enrollment
641 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2012 (Type not available)
Primary completion
Apr 2015 (Actual)
Completion
Apr 2015 (Actual)
Last update posted
Aug 17, 2016

2012 – 2015

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
Research Site Phoenix Arizona 85006 —
Research Site Phoenix Arizona 85054 —
Research Site Scottsdale Arizona 85258 —
Research Site Sun City Arizona 85351 —
Research Site Clearwater Florida 33756 —
Research Site Miami Beach Florida 33140 —
Research Site Orlando Florida 32806 —
Research Site West Palm Beach Florida 33407 —
Research Site Shreveport Louisiana 71130 —
Research Site Boston Massachusetts 02115 —
Research Site Chestnut Hill Massachusetts 02467 —
Research Site Quincy Massachusetts 02169 —
Research Site Las Vegas Nevada 89106 —
Research Site Las Vegas Nevada 89128 —
Research Site Patchogue New York 11772 —
Research Site Durham North Carolina 27710 —
Research Site Greensboro North Carolina 27405 —
Research Site Providence Rhode Island 02903 —
Research Site Providence Rhode Island 02906 —
Research Site Salt Lake City Utah 84108 —
Research Site Bennington Vermont 05201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01703702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2016 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01703702 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →